Rufinamide for Pediatric Patients with Lennox-Gastaut Syndrome: A Comprehensive Overview

Author： >

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.13, Iss.2, 2011-04, pp. : 97-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rufinamide for the treatment of Lennox––Gastaut syndrome

By Besag Frank MC

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 801-806

Informa Healthcare

Access to resources Recommend Favorite

Rufinamide: a guide to its use in Lennox-Gastaut syndrome

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 6-9

Adis International

Access to resources Recommend Favorite

Rufinamide: A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome

By McCormack Paul L.

PharmacoEconomics, Vol. 30, Iss. 3, 2012-03 ,pp. : 247-256

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK

By Benedict Ágnes

PharmacoEconomics, Vol. 28, Iss. 3, 2010-03 ,pp. : 185-199

Adis International

Access to resources Recommend Favorite

Rufinamide improves outlook in poorly controlled Lennox-Gastaut

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite